Information Journal Paper
APA:
CopyRUGGENENTI, P., REMUZZI, A., & ONDEI, P.. (2005). SAFETY AND EFFICACY OF LONG-ACTING SOMATOSTATIN TREATMENT IN AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY DISEASE. KIDNEY INTERNATIONAL, 68(1), 206-216. SID. https://sid.ir/paper/588296/en
Vancouver:
CopyRUGGENENTI P., REMUZZI A., ONDEI P.. SAFETY AND EFFICACY OF LONG-ACTING SOMATOSTATIN TREATMENT IN AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY DISEASE. KIDNEY INTERNATIONAL[Internet]. 2005;68(1):206-216. Available from: https://sid.ir/paper/588296/en
IEEE:
CopyP. RUGGENENTI, A. REMUZZI, and P. ONDEI, “SAFETY AND EFFICACY OF LONG-ACTING SOMATOSTATIN TREATMENT IN AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY DISEASE,” KIDNEY INTERNATIONAL, vol. 68, no. 1, pp. 206–216, 2005, [Online]. Available: https://sid.ir/paper/588296/en